← FDA Drug Approvals (Drugs@FDA)

REVONTO

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: USWM · Approved 2007-07-24

Drug application

FDA Application #

ANDA078378

Application type

Abbreviated New Drug Application (Generic)

Brand name

REVONTO

Generic name

DANTROLENE SODIUM

Active ingredients

DANTROLENE SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

USWM

Manufacturer

USWM, LLC

First approval

2007-07-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown